NCT Number: NCT02993445
Effect of Alternate Therapies on Intraocular Pressure in Ocular Hypertension
The purpose of this study is to evaluate the effect of complementary and alternative therapies, specifically alternate nostril breathing and foot reflexology, on intraocular pressure in patients with ocular hypertension.
Looking for future studies?
Notify MeKey information
Conditions
Age range
30 year–90 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
About this study
11 patients were recruited from Temple Ophthalmology between 2014 and 2016. Patients had ocular hypertension and were between the ages of 48-74. Patients were excluded if they currently performed ANB or FR, were unable to perform the task, had previous eye surgery or laser, were receiving other CAM for ocular hypertension, or were unable to complete a washout period. After a 30-day drug washout, patients completed either ANB or FR. After instruction, the assigned task was performed for 5 minutes. FR was done on a commercially available foot reflexology board (JAPAN TSUBO HH-700) focused at the base of the second and third toes of both feet. Two weeks later, patients completed the alternate task. IOP was measured before the task, immediately after the task and then every 30 minutes for two hours. Sign rank tests were used to evaluate IOP changes within and between each group.
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- patients with ocular hypertension
Exclusion criteria
- currently performed alternate nostril breathing or foot reflexology
- were unable to perform the task
- had previous eye surgery or laser,
- were receiving other CAM for ocular hypertension
- were unable to complete a washout period if they using glaucoma eye drops
Treatment and study plan
Foot Reflexology
DevicePrimary outcomes
-
Change From Baseline in Intraocular Pressure (mmHg)
Time frame: 2 hours
Measurement of intraocular pressure after each treatment for 30min intervals for total of 2hours. Time points used in the calculation include baseline, 30 mins, 60 mins, 90 mins, and 120 mins.
-
Change From Baseline in Intraocular Pressure (mmHg)
Time frame: 2 hours
Measurement of intraocular pressure after each treatment for 30min intervals for total of 2hours. Time points used in the calculation include baseline, 30 mins, 60 mins, 90 mins, and 120 mins.
This is after the 2 week washout period. Participants have switched interventions
Sponsors and collaborators
Lead sponsor
Temple University
Other
Registry information
Official study title
A Pilot Study on the Effect of Alternate Nostril Breathing and Foot Reflexology on Intraocular Pressure in Ocular Hypertension
Important dates
- Study start
- 2014
- Primary completion
- 2016
- Study completion
- 2016
- First posted
- Dec 15, 2016
- Registry last updated
- Nov 27, 2020
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Prophylactic Use of Timolol Maleate to Prevent Intraocular Pressure Elevation After Nd:YAG Laser Posterior Capsulotomy
NCT07729189
Capsule Opacification, Cataract
Multan, Punjab Province, Pakistan
View Trial DetailsLong-term Safety and Efficacy Extension Trial of Bimatoprost SR
NCT03891446
Eye Diseases, Glaucoma
Dothan, Alabama, United States
View Trial DetailsSD-OCT Multimodal Analysis in GLaucoma
NCT02710916
Eye Diseases, Glaucoma
Bordeaux, Aquitaine, France
View Trial DetailsReformulated PG324 Ophthalmic Solution for Intraocular Pressure Reduction
NCT07082816
Eye Diseases, Glaucoma
Dothan, Alabama, United States
View Trial Details